Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

Homecompany8-Bromo-3-methyl-7-but-2-ynyl xanthine 666816-98-4 99%
8-Bromo-3-methyl-7-but-2-ynyl xanthine
8-Bromo-3-methyl-7-but-2-ynyl xanthine
8-Bromo-3-methyl-7-but-2-ynyl xanthine

8-Bromo-3-methyl-7-but-2-ynyl xanthine 666816-98-4 99%

Price Get Latest Price
Packge 1MT1kg5kg10kg25kg
  • Min. Order:1MT
  • Time:2024-01-12

Product Details

  • Product Name8-Bromo-3-methyl-7-but-2-ynyl xanthine
  • CAS No.666816-98-4
  • EINECS No.613-975-8
  • MFC10H9BrN4O2
  • MW297.11
  • Appearancepowder to crystalWhite to Almost white
  • density 1.71
  • Melting point 285 °C
  • storage temp. 2-8°C

Company Profile Introduction

PSN MEDICARE is promoted by highly qualified and experienced professionals having two decades of experience in pharmaceutical industry. The company performs research and development work for major pharmaceutical and biotechnology compounds, identifying and developing compounds for their drug development. All services are carried out by experienced team of scientist and the team directly interacts and communicates with client. We will assure complete confidentiality with customer's all intellectual properties.

PSN MEDICARE  is a manufacturing and marketing of high profile Active Pharmaceutical Ingredients, and its Intermediates, came into existence in the year, 2014.
PSN MEDICARE is having manufacturing units with state-of-the-art facilities at IDA Bollaram, Hyderabad, Telangana, INDIA. The company has metamorphosed into a manufacturer of bulk actives and its intermediates, catering to the needs of a wide range of therapeutic areas, by the way of investing brains and experience, with thoughts and vision for a better tomorrow.

PSN Medicare Private Limited

1Y Telangana India
  • Since:2020-01-01
  • Address: Sy. No.296/7/11, IDA. Bollaram, Jinnaram Mandal, Medak, Telangana-502 325, India
INQUIRY